Thrombomodulin-Induced Prevention of Peripheral Neuropathy in Oxaliplatin-Treated Mice Involves Complement C5a Inactivation and PAR1 Activation in Addition To HMGB1 Degradation
Authors:
- Kengo MaruoKMKengo Maruo
- Maho TsubotaMTMaho Tsubota
- Kazuki TajimaKTKazuki Tajima
- Hiroaki MatsunagaHMHiroaki Matsunaga
- Fumiko SekiguchiFSFumiko Sekiguchi
- Tatsuro MinamiTMTatsuro Minami
- Akitoshi ItoAIAkitoshi Ito
- Yasuko TomonoYTYasuko Tomono
- Masahiro NishiboriMNMasahiro Nishibori
- Atsufumi KawabataAtsufumi Kawabata
- 4 November 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 20 (1) , 1-15
Abstract
High mobility group box 1 (HMGB1), a nuclear protein, once released to the extracellular space, participates in the pathogenesis of chemotherapy-induced peripheral neuropathy (CIPN). Thrombomodulin alfa (TMα), a recombinant soluble protein of endothelial thrombomodulin, prevents CIPN by promoting thrombin-dependent HMGB1 degradation and activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI/plasma carboxypeptidase B/CPB2). We thus investigated the downstream molecules of activated protein C (APC) and TAFI (TAFIa), for prevention of oxaliplatin-induced peripheral neuropathy (OIPN) in mice. OIPN was prevented by TMα and by each of an anti-HMGB1-neutralizing antibody (HAb), APC and porcine pancreatic carboxypeptidase B (ppCPB, used as a stable surrogate of TAFIa), or their combination at subeffective doses. Intraplantar administration of HMGB1 induced mechanical allodynia, which was abolished by TMα, but not APC or ppCPB. The anti-OIPN effects of TMα and APC were reversed by an antagonist of proteinase-activated receptor 1 (PAR1), targetable by APC, and the effect of TMα was also reversed by a CPB inhibitor. Intraplantar administration of mouse C5a (mC5a), targetable by TAFIa, caused mechanical allodynia, an effect blocked by TMα, a mC5a receptor (mC5aR) antagonist or HAb. The mC5aR antagonist prevented OIPN development. Oxaliplatin significantly increased plasma C5a levels in the mice treated with argatroban, a thrombin inhibitor, capable of reducing the degradation of HMGB1 by the endogenous thrombin-thrombomodulin axis. Our data thus suggest that the anti-OIPN effect of TMα involves APC-induced PAR1 activation and TAFIa-induced degradation of C5a that induces HMGB1-dependent pain, in addition to HMGB1 degradation. Graphical AbstractKeywords
Funding Information
- Japan Society for the Promotion of Science (23K06372, 21K06608)
This publication has 50 references indexed in Scilit:
- Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR AxisPain and Therapy, 2022
- Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson’s diseaseBiomedicine & Pharmacotherapy, 2022
- A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathyCancer Chemotherapy and Pharmacology, 2020
- Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activityEuropean Journal of Pharmacology, 2020
- Human soluble thrombomodulin-induced blockade of peripheral HMGB1-dependent allodynia in mice requires both the lectin-like and EGF-like domainsBiochemical and Biophysical Research Communications, 2018
- Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in MiceJournal of Neuroimmune Pharmacology, 2017
- Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 AxisJournal of Neuroimmune Pharmacology, 2017
- Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cellsBiochemical Pharmacology, 2015
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerveBrain Research, 1979